Blackwood, Jennifer
Daya, Mohamud R.
Sorenson, Ben
Schaeffer, Brian
Dawson, Mike
Charter, Michael
Nania, James Mark
Charbonneau, Julie
Robertson, Jeremy
Mancera, Michael
Carbon, Chris
Jorgenson, Dawn B.
Gao, Mengqi
Price, Richard
Rosse, Chris
Rea, Thomas
Funding for this research was provided by:
Philips Medical
Article History
Received: 26 August 2022
Accepted: 13 July 2023
First Online: 27 July 2023
Declarations
:
: All methods for this study were carried out in accordance with relevant guidelines and regulations pertaining to research involving human participants. The study was approved by the University of Washington Investigational Review Board (STUDY00001970). The study was determined to be minimal risk and so individual consent was not required. The need for informed consent was waived by the Institutional Review Board of University of Washington, because the study was determined to be minimal risk and has no effect on the standard of care for treatment of subjects. The program was also approved by the command staff of Spokane Fire Department, Spokane Valley Fire Department, Sioux Falls Fire Department, and Tualatin Valley Fire & Rescue.
: Not applicable.
: Drs. Jorgenson and Gao are employees of Philips Medical. Mr. Price is an employee of PulsePoint. Research for the current investigation is supported by a grant provided by the Philips Foundation for which Ms. Blackwood received funding. All other authors declare that they have no competing interests.AEDs were also generously provided by Philips Medical to participating Verified Responder agencies.